These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6753451)

  • 1. Monitoring acetazolamide treatment.
    Alm A; Berggren L; Hartvig P; Roosdorp M
    Acta Ophthalmol (Copenh); 1982 Feb; 60(1):24-34. PubMed ID: 6753451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of acetazolamide in patients with transient intraocular pressure elevation.
    Yano I; Takayama A; Takano M; Inatani M; Tanihara H; Ogura Y; Honda Y; Inui K
    Eur J Clin Pharmacol; 1998 Mar; 54(1):63-8. PubMed ID: 9591933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure.
    Rulo AH; Greve EL; Hoyng PF
    Ophthalmology; 1997 Sep; 104(9):1503-7. PubMed ID: 9307648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraocular and intracranial pressure in glaucoma patients taking acetazolamide.
    Loiselle AR; de Kleine E; van Dijk P; Jansonius NM
    PLoS One; 2020; 15(6):e0234690. PubMed ID: 32555666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
    Rosenberg LF; Krupin T; Tang LQ; Hong PH; Ruderman JM
    Ophthalmology; 1998 Jan; 105(1):88-92; discussion 92-3. PubMed ID: 9442783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between acetazolamide blood concentration and its side effects in glaucomatous patients.
    Inatani M; Yano I; Tanihara H; Ogura Y; Honda Y; Inui KI
    J Ocul Pharmacol Ther; 1999 Apr; 15(2):97-105. PubMed ID: 10229487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equivalence of conventional and sustained release oral dosage formulations of acetazolamide in primary open angle glaucoma.
    Joyce PW; Mills KB; Richardson T; Mawer GE
    Br J Clin Pharmacol; 1989 May; 27(5):597-606. PubMed ID: 2757882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetazolamide dosage forms in the treatment of glaucoma.
    Berson FG; Epstein DL; Grant WM; Hutchinson BT; Dobbs PC
    Arch Ophthalmol; 1980 Jun; 98(6):1051-4. PubMed ID: 6770801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic Effect of Oral Acetazolamide against Intraocular Pressure Elevation after Cataract Surgery in Eyes with Glaucoma.
    Hayashi K; Yoshida M; Manabe SI; Yoshimura K
    Ophthalmology; 2017 May; 124(5):701-708. PubMed ID: 28110949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The additive effect of topical dorzolamide and systemic acetazolamide in pediatric glaucoma.
    Sabri K; Levin AV
    J AAPOS; 2006 Oct; 10(5):464-8. PubMed ID: 17070484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetazolamide influences ocular pulse amplitude.
    Zinkernagel MS; Ebneter A
    J Ocul Pharmacol Ther; 2009 Apr; 25(2):141-4. PubMed ID: 19284322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Acetazolamide and Weight Loss on Intraocular Pressure in Idiopathic Intracranial Hypertension Patients.
    Banik R; Kupersmith MJ; Wang JK; Garvin MK;
    J Glaucoma; 2019 Apr; 28(4):352-356. PubMed ID: 30624392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the ocular hypotensive effect of acetazolamide by diflunisal.
    Yablonski ME; Maren TH; Hayashi M; Naveh N; Potash SD; Pessah N
    Am J Ophthalmol; 1988 Sep; 106(3):332-6. PubMed ID: 3048109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors and osmotic agents in glaucoma. Carbonic anhydrase inhibitors.
    Kanski JJ
    Br J Ophthalmol; 1968 Aug; 52(8):642-3. PubMed ID: 5724852
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ocular hypotonic effect of hematic acidifying agents: carbonic anhydrase inhibitors].
    Virno M; Pecori-Giraldi J; Pivetti-Pezzi P; Leonardi E
    Boll Ocul; 1970 Sep; 49(9):469-91. PubMed ID: 5522152
    [No Abstract]   [Full Text] [Related]  

  • 16. Short-term dose response characteristics of acetazolamide in man.
    Friedland BR; Mallonee J; Anderson DR
    Arch Ophthalmol; 1977 Oct; 95(10):1809-12. PubMed ID: 334132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigations on the effect of various doses of acetazolamide (Diamox) on intraocular pressure (author's transl)].
    Merté HJ; Heilmann K; Hollwich I
    Klin Monbl Augenheilkd; 1977 Mar; 170(3):473-9. PubMed ID: 325284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argon laser peripheral iridoplasty versus conventional systemic medical therapy in treatment of acute primary angle-closure glaucoma : a prospective, randomized, controlled trial.
    Lam DS; Lai JS; Tham CC; Chua JK; Poon AS
    Ophthalmology; 2002 Sep; 109(9):1591-6. PubMed ID: 12208703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient tolerance to carbonic anhydrase inhibitors.
    Lichter PR; Newman LP; Wheeler NC; Beall OV
    Am J Ophthalmol; 1978 Apr; 85(4):495-502. PubMed ID: 655230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term changes in intraocular pressure after phacoemulsification in glaucoma patients.
    Fogagnolo P; Centofanti M; Figus M; Frezzotti P; Fea A; Ligorio P; Lembo A; Digiuni M; Lorenzi U; Rossetti L
    Ophthalmologica; 2012; 228(3):154-8. PubMed ID: 22572718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.